Table 3.
Anemia leads to abnormal blood zinc levels in bodies.
| ||||
|
Controls | CKD patients | p value | Reference |
(µg/mL plasma) | a. 1.07 ± 4 (n = 11) | 0.82 ± 0.04 (n = 10) | <0.01 | [105] |
b. 1.016 ± 0.022(n = 50) | 0.80 ± 0.03 (n = 10) | <0.001 | [106] | |
c. 1.14 ± 0.11 (n = 25) | 0.95 ± 0.10 (n = 26) | <0.001 | [109] | |
d. 1.105 ± 0.175(n= 152) | 0.705 ± 0.128 (n = 456) | <0.0001 | [103] | |
e. 0.93 ± 0.12 (n = 20) | 0.81 ± 0.19 (n = 30) | <0.05 | [110] | |
f. 0.98 ± 0.15 (n = 11) | 0.49 ± 0.18 (n = 127) | <0.0001 | [64] | |
-----Lower plasma zinc levels in CKD patients----- | ||||
|
||||
(µg/g Hb) | a. 44.1 ± 1.1 (n = 50) | 55.0 ± 2.0 (n = 10) | <0.001 | [106] |
b. 41.8 ± 63.0 (n = 20) | 51.3 ± 10.3 (n = 30) | <0.05 | [110] | |
(µmoles/L) | c. 148 ± 13 (n = 10) | 198 ± 8 (n = 10) | <0.05 | [108] |
(mg/L) | d. 12.1 ± 1.2 (n = 25) | 13.4 ± 3.1 (n = 26) | <0.001 | [109] |
(µg/109 RBC) | e. 0.63 ± 0.06 (n = 21) | 0.72 ± 0.18 (n = 127) | <0.05 | [64] |
-----Higher erythrocyte zinc levels in CKD patients----- | ||||
| ||||
(1) Plasma zinc levels (µg/mL plasma) | Controls | Anemic rats | p value | Reference |
a. 5/6 nephrectomized anemic rats | ||||
1.90 ± 0.3 (n = 6) | 1.40 ± 0.2 (n = 6) | <0.05 | [64] | |
b. Phenylhydrazine induced anemic rats | ||||
1.45 ± 0.06 (n = 6) | 1.29 ± 0.03(n = 6) | <0.001 | [64] | |
-----Lower plasma zinc levels in anemic rats----- | ||||
(2) Erythrocyte zinc levels (µg/109 RBC) | ||||
a. 5/6 nephrectomized anemic rats | ||||
0.50 ± 0.08 (n = 6) | 0.90 ± 0.01 (n = 6) | <0.001 | [64] | |
b. Phenylhydrazine induced anemic rats | ||||
0.70 ± 0.21 (n = 6) | 0.86 ± 0.10 (n = 6) | <0.01 | [64] | |
-----Higher erythrocyte zinc levels in anemic rats----- | ||||
|